Hematopoiese
Gabrilovich, Nat Rev Immunol, 2012
LymphNode
Bone Marrow
BloodBlood
Tissues
FL
MPP : progéniteur multipotent
CMLP : progéniteur myélo-lympho commun
CLP : progéniteur lymphoïde commun
CMP : progéniteur myéloïde commun
CDP : progéniteur DC commun
GMP : progéniteur granuleux et macrophages
MCP progéniteur mastocytes
MDP : progéniteur macrophage et DC
MEP : progéniteur megacaryocyte et érythroïde
Microenvironment and cancer
Wolf-Herman, Nat Rev Cancer, 2012De Visser, Nat Rev Cancer, 2006
FL
Microenvironment and cancer
Narendra, Inflamm Res, 2013
FL
Populations myéloides suppressives
• Suppressive = régulatrice = immunomodulatrice• Supprime la réponse T et NK
Large family of tolerogenic cells:• Treg,• Breg,• tolerogenic DC,• MSC,• regulatory macrophages,• MDSC
• turn-on / turn-off• Complex regulation• Impair T effector and NK functions
• IL-10, TGF-b• aa depletion (IDO, Arginase)
Gabrilovich, Nat Rev Immunol, 2012
Changes that occur in myeloid cells in cancer
DC :-APC-activate T-link between innate and adaptative
Monocyte-in blood-APC ((<DC)-Phagocytosis-Cytokine production-migrate to the tissue
Macrophage-in tissue-APC-Phagocytosis-Inflammation/anti-inflammation
Gabrilovich, Nat Rev Immunol, 2012
Changes that occur in myeloid cells in cancer
MDSC:1-Immature state2-Myeloid origin3-Supress T-cell responses
4-Regulate innate immune responses:modulation the cytokine production ofmacrophages
5-Non-immunological functions:promote angiogenesispromote metastasis
Gabrilovich, Nat Rev Immunol, 2012
Changes that occur in myeloid cells in cancer
• Support tumor growth• suppress anti-tumor immunity
• Support angiogenesis/metastasis• soluble factors
• Potential immunotherapy target
Physiological pathsCancer/Sepsis
Gabrilovich, Nat Rev Immunol, 2009
Inhibition of diff
Stimulation of myelopoiesis
Signaling pathways involved in MDSC expansion
Gabrilovich, Nat Rev Immunol, 2009
Signaling pathways involved in MDSC activation
Top Related